DelRicht Research is a clinical research site located in Tulsa, Oklahoma, United States 74133.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
DelRicht Research has participated in 16 clinical trials with 5 currently active.
Therapeutic areas: SARS-CoV-2, Diabetic Peripheral Neuropathic Pain, Migraine.
Sponsors: ModernaTX, Inc., Eli Lilly and Company, Atom Therapeutics Co., Ltd.
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
DelRicht Research has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
DelRicht Research has 16 clinical trials on record, with 5 currently active. Their work covers SARS-CoV-2, Diabetic Peripheral Neuropathic Pain, Migraine.
Yes — DelRicht Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.